Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
Number of items: 88.

2022

Bethge, Wolfgang A., Martus, Peter, Schmitt, Michael, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner-Drouet, Eva Marie, Wulf, Gerald G., Marks, Reinhard, Penack, Olaf, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte ORCID: 0000-0002-2995-3230, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Fante, Matthias A., Schroers, Roland, Bayir, Lale, Borchmann, Peter, Buecklein, Veit, Hasenkamp, Justin, Hanoun, Christine, Thomas, Simone, Beelen, Dietrich W., Lengerke, Claudia, Kroeger, Nicolaus and Dreger, Peter (2022). GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood, 140 (4). S. 349 - 359. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Brockelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2022). Novel therapeutic approaches in relapsed or refractory Hodgkin lymphoma. Onkologie, 28 (10). S. 901 - 908. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234

Broeckelmann, Paul J., Buehnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa, V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial. Blood, 140. S. 1753 - 1756. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Mueller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis. Leukemia, 36 (3). S. 772 - 781. LONDON: SPRINGERNATURE. ISSN 1476-5551

Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Pluetschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Soekler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter and Eichenauer, Dennis A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia, 36 (2). S. 580 - 583. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buehnen, Ina, Pluetschow, Annette, Kobe, Carsten, Dietlein, Markus, Wendtner, Clemens-Martin, Thorspecken, Sven, Topp, Max S., Mauser, Mareike, von Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Hematol. Oncol., 40 (4). S. 801 - 805. HOBOKEN: WILEY. ISSN 1099-1069

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buhnen, Ina, Kreissl, Stefanie, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Rosenwald, Andreas, Klapper, Wolfram, Hansmann, Martin-Leo, Moller, Peter, Bernd, Heinz-Wolfram, Feller, Alfred C., Engert, Andreas, Borchmann, Peter and Hartmann, Sylvia (2022). Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group. Br. J. Haematol., 196 (1). S. 99 - 105. HOBOKEN: WILEY. ISSN 1365-2141

Fluemann, Ruth, Hansen, Julia, Pelzer, Benedikt, Kiss, Ilmars, Lohmann, Tim, Persigehl, Thorsten, Abedpour, Nima, Peifer, Martin, Buettner, Reinhard, von Tresckow, Bastian, Jachimowicz, Ron, Reinhardt, Hans Christian and Knittel, Gero (2022). Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL. Blood, 140. S. 3493 - 3495. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason ORCID: 0000-0002-6422-4404, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie Jose, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Perez-Simon, Jose Antonio, Chen, Andy, I, Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andres Jose Maria, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J. and Thieblemont, Catherine (2022). Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nat. Med., 28 (2). S. 325 - 343. BERLIN: NATURE PORTFOLIO. ISSN 1546-170X

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609

Graef, Claus Moritz, Goedel, Philipp, Falderbaum, Philipp, Balke-Want, Hyatt, Simon, Florian ORCID: 0000-0002-2700-3717, Sieg, Noelle, Naendrup, Jan-Hendrik, Neumann, Marie Anne-Catherine ORCID: 0000-0002-2396-6110, Gillessen, Sarah, Broeckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2022). Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma. Eur. J. Haematol., 108 (5). S. 403 - 413. HOBOKEN: WILEY. ISSN 1600-0609

Heger, Jan-Michel, Mattlener, Julia, Godel, Philipp, Balke-Want, Hyatt, Sieg, Noelle, Kutsch, Nadine, Becker, Kerstin, Weiss, Jonathan, Reinhardt, H. Christian, Hallek, Michael, Borchmann, Peter, von Tresckow, Bastian and Borchmann, Sven (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood, 140. S. 3537 - 3539. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Momotow, Jesko, Buehnen, Ina, Trautmann-Grill, Karolin, Kobbe, Guido, Hahn, Dennis, Schroers, Roland ORCID: 0000-0003-2744-5491, Heinrich, Bernhard, Gaska, Tobias, Forstbauer, Helmut, Schmidt, Burkhard, Boger, Regina, Huettmann, Andreas, Heil, Gerhard, Kraemer, Doris M., Krueger, William, Zeremski, Vanja, Grobe, Norbert, Jentsch-Ullrich, Kathleen, Griesinger, Frank, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Engert, Andreas and Broeckelmann, Paul J. (2022). Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. Br. J. Haematol., 198 (2). S. 401 - 405. HOBOKEN: WILEY. ISSN 1365-2141

Salles, Gilles ORCID: 0000-0002-9541-8666, Schuster, Stephen J., Dreyling, Martin, Fischer, Luca ORCID: 0000-0003-2444-416X, Kuruvilla, John, Patten, Piers E. M., von Tresckow, Bastian, Smith, Sonali M., Jimenez-Ubieto, Ana ORCID: 0000-0003-0892-8682, Davis, Keith L., Anjos, Carla, Chu, Jufen, Zhang, Jie, Bodoni, Chiara Lobetti, Thieblemont, Catherine, Fowler, Nathan H., Dickinson, Michael, Martinez-Lopez, Joaquin, Wang, Yucai and Link, Brian K. (2022). Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. Blood Adv., 6 (22). S. 5835 - 5844. AMSTERDAM: ELSEVIER. ISSN 2473-9537

Salles, Gilles, Schuster, Stephen J., Fischer, Luca, Kuruvilla, John, Patten, Piers Em, von Tresckow, Bastian, Smith, Sonali M., Ubieto, Ana Isabel Jiminez, Davis, Keith L., Nagar, Saurabh P. ORCID: 0000-0003-4616-0926, Zhang, Jie, Bollu, Vamsi, Jousseaume, Etienne, Ramos, Roberto, Wang, Yucai and Link, Brian K. (2022). A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL). Hemasphere, 6 (7). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

2021

Brockelmann, Paul J., Muller, Horst, Guhl, Teresa, Behringer, Karolin, Fuchs, Michael ORCID: 0000-0003-3289-3272, Moccia, Alden A., Rank, Andreas, Soekler, Martin, Vieler, Tom, Pabst, Thomas, Baues, Christian, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. J. Clin. Oncol., 39 (2). S. 107 - 122. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Muller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Boll, Boris, Diehl, Volker, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br. J. Haematol., 193 (3). S. 515 - 520. HOBOKEN: WILEY. ISSN 1365-2141

Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther ORCID: 0000-0002-1495-9162, Mueller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Moeller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael and Rosenwald, Andreas (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35 (12). S. 3589 - 3594. LONDON: SPRINGERNATURE. ISSN 1476-5551

Jachimowicz, Ron Daniel, Pieper, Luise, Reinke, Sarah, Gontarewicz, Artur, Pluetschow, Annette, Haverkamp, Heinz, Frauenfeld, Leonie, Fend, Falko, Overkamp, Mathis, Jochims, Franziska, Thorns, Christoph, Hansmann, Martin Leo, Moller, Peter, Rosenwald, Andreas, Stein, Harald, Reinhardt, Hans Christian, Borchmann, Peter, von Tresckow, Bastian, Engert, Andreas and Klapper, Wolfram (2021). Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica, 106 (6). S. 1684 - 1693. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Sieg, Noelle, Naendrup, Jan-Hendrik, Goedel, Philipp, Balke-Want, Hyatt, Simon, Florian, Deckert, Martina, Gillessen, Sarah, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel (2021). Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine. Eur. J. Haematol., 107 (2). S. 202 - 211. HOBOKEN: WILEY. ISSN 1600-0609

Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Mueller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten and Broeckelmann, Paul J. (2021). Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin. Cancer Res., 27 (2). S. 402 - 408. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

2020

Aldin, Angela, Umlauff, Lisa, Estcourt, Lise J., Collins, Gary, Moons, Karel G. M., Engert, Andreas, Kobe, Carsten, von Tresckow, Bastian, Haque, Madhuri, Foroutan, Farid, Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Trivella, Marialena and Skoetz, Nicole (2020). Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Broeckelmann, Paul J. and von Tresckow, Bastian ORCID: 0000-0003-1410-4487 (2020). Risk stratification and prognostic biomarkers in relapsed Hodgkin lymphoma. Br. J. Haematol., 190 (6). S. 813 - 815. HOBOKEN: WILEY. ISSN 1365-2141

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Hartmann, Sylvia, Hansmann, Martin-Leo, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2020). Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group. Leukemia, 34 (3). S. 953 - 957. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Sasse, Stephanie, Baues, Christian, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2020). Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 38 (7). S. 698 - 707. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gillessen, Sarah, Kobe, Carsten, Engert, Andreas and von Tresckow, Bastian (2020). PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma. Leuk. Lymphoma, 61 (2). S. 251 - 255. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Soekler, Martin, Markova, Jana, Bernhard, Jurg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rueffer, Jens-Ulrich, Flechtner, Hans-Henning, Moestl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker and Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. J. Clin. Oncol., 38 (25). S. 2839 - 2857. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Zinzani, Pier Luigi, Chen, Robert, Armand, Philippe, Johnson, Nathalie A., Brice, Pauline, Radford, John ORCID: 0000-0001-7898-2786, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Lin, Jianxin, Nahar, Akash, Balakumaran, Arun and Moskowitz, Craig H. (2020). Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis. Leuk. Lymphoma, 61 (4). S. 950 - 955. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

2019

Aldin, Angela, Umlauff, Lisa, Estcourt, Lise J., Collins, Gary ORCID: 0000-0002-2772-2316, Moons, Karel G. M., Engert, Andreas, Kobe, Carsten, von Tresckow, Bastian, Haque, Madhuri, Foroutan, Farid, Kreuzberger, Nina, Trivella, Marialena ORCID: 0000-0003-4492-1760 and Skoetz, Nicole (2019). Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database Syst Rev. (9). HOBOKEN: WILEY. ISSN 1361-6137

Boell, Boris, Pluetschow, Annette, Buerkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring-Buske, Michaela, Vogelhuber, Martin, Soekler, Martin, Eichenauer, Dennis A., Thielen, Indra, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2019). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. Br. J. Haematol., 185 (1). S. 42 - 53. HOBOKEN: WILEY. ISSN 1365-2141

Borchmann, Sven, Cirillo, Melita, Goergen, Helen, Meder, Lydia ORCID: 0000-0002-9547-5812, Sasse, Stephanie, Kreissl, Stefanie, Broeckelmann, Paul Jan, von Tresckow, Bastian, Fuchs, Michael, Ullrich, Roland Tillmann and Engert, Andreas (2019). Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. J. Clin. Oncol., 37 (36). S. 3528 - 3539. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Chen, Robert, Zinzani, Pier Luigi, Lee, Hun Ju, Armand, Philippe, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Lin, Jianxin, Kim, Eunhee, Nahar, Akash, Balakumaran, Arun and Moskowitz, Craig H. (2019). Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087. Blood, 134 (14). S. 1144 - 1154. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Tresckow, Bastian, Fanale, Michelle, Ardeshna, Kirit M., Chen, Robert, Meissner, Julia, Morschhauser, Franck, Moskowitz, Craig, Zinzani, Pier Luigi, Giezek, Hilde, Balakumaran, Arun, Vo, Thao T., Raut, Monika and Brice, Pauline (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leuk. Lymphoma, 60 (11). S. 2705 - 2712. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

von Tresckow, Bastian, Sayehli, Cyrus, Aulitzky, Walter E., Goebeler, Maria-Elisabeth, Schwab, Matthias, Braz, Eunice, Krauss, Babett, Krauss, Rolf, Hermann, Frank, Bartz, Rene and Engert, Andreas (2019). Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies. Eur. J. Haematol., 102 (2). S. 163 - 174. HOBOKEN: WILEY. ISSN 1600-0609

2018

Broeckelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2018). Relapsed or refractory classical Hodgkin's lymphoma. Novel therapeutic approaches. Onkologe, 24 (4). S. 322 - 329. NEW YORK: SPRINGER. ISSN 1433-0415

Collins, Graham P., Rueda, Antonio, Salles, Gilles, von Tresckow, Bastian and Zaja, Francesco ORCID: 0000-0003-3995-8817 (2018). Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries. Leuk. Lymphoma, 59 (9). S. 2113 - 2121. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2018). Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Blood, 132 (14). S. 1519 - 1526. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goldkuhle, Marius, Dimaki, Maria, Gartlehner, Gerald ORCID: 0000-0001-5531-3678, Monsef, Ina, Dahm, Philipp, Glossmann, Jan-Peter, Engert, Andreas, von Tresckow, Bastian and Skoetz, Nicole (2018). Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). Cochrane Database Syst Rev. (7). HOBOKEN: WILEY. ISSN 1361-6137

Hude, Ida, Sasse, Stephanie, Broeckelmann, Paul J., von Tresckow, Bastian, Momotow, Jesko, Engert, Andreas and Borchmann, Sven (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. Br. J. Haematol., 181 (6). S. 837 - 841. HOBOKEN: WILEY. ISSN 1365-2141

Sasse, Stephanie, Goergen, Helen, Pluetschow, Annette, Boell, Boris, Eichenauer, Dennis A., Fuchs, Michael, Behringer, Karolin, Zijlstra, Josee M., Greil, Richard, Markova, Jana, Topp, Max S., Meissner, Julia, Neubauer, Andreas, Baues, Christian, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2018). Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 36 (25). S. 2603 - 2621. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Walewski, Jan ORCID: 0000-0003-4247-2674, Hellmann, Andrzej, Siritanaratkul, Noppadol, Ozsan, Guner Hayri, Ozcan, Muhit, Chuncharunee, Suporn, Goh, Ai Sim, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Koren, Jan, Paszkiewicz-Kozik, Ewa, Wang, Bingxia, Singh, Shalini, Huebner, Dirk, Engert, Andreas and von Tresckow, Bastian (2018). Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy. Br. J. Haematol., 183 (3). S. 400 - 411. HOBOKEN: WILEY. ISSN 1365-2141

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Brockelmann, Paul J., Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Burkle, Carolin, Baues, Christian, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. Lancet Haematol., 5 (10). S. E462 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

2017

Blank, Oliver, von Tresckow, Bastian, Monsef, Ina, Specht, Lena ORCID: 0000-0002-6902-2190, Engert, Andreas and Skoetz, Nicole (2017). Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma. Cochrane Database Syst Rev. (4). HOBOKEN: WILEY. ISSN 1361-6137

Borchmann, Sven and von Tresckow, Bastian (2017). Novel agents in classical Hodgkin lymphoma. Leuk. Lymphoma, 58 (10). S. 2275 - 2287. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Chen, Robert, Zinzani, Pier Luigi, Fanale, Michelle A., Armand, Philippe, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Zhang, Yinghua, Ricart, Alejandro D., Balakumaran, Arun and Moskowitz, Craig H. (2017). Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. J. Clin. Oncol., 35 (19). S. 2125 - 2135. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Skoetz, Nicole, Will, Andrea, Monsef, Ina, Brillant, Corinne, Engert, Andreas and von Tresckow, Bastian (2017). Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev. (5). HOBOKEN: WILEY. ISSN 1361-6137

von Tresckow, Bastian, Morschhauser, Franck, Szer, Jeffrey, Eichenauer, Dennis A., Abramson, Jeremy S., Sureda, Anna and Engert, Andreas (2017). Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation. Leuk. Lymphoma, 58 (1). S. 222 - 226. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

2016

Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Sven, von Tresckow, Bastian and Engert, Andreas (2016). Current developments in the treatment of early-stage classical Hodgkin lymphoma. Curr. Opin. Oncol., 28 (5). S. 377 - 384. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2016). Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, von Tresckow, Bastian, Goergen, Helen, Haverkamp, Heinz, Sasse, Stephanie, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Beacoppescalated Followed By Radiotherapy of Initial Bulk or Residual Disease in Advanced Stage Hodgkin Lymphoma: Long-Term Follow up of the HD9 and HD12 Trials of the German Hodgkin Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Moskowitz, Craig H., Zinzani, Pier Luigi, Fanale, Michelle A., Armand, Philippe, Johnson, Nathalie A., Radford, John A., Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Gustafson, Eric, Zhang, Yinghua, Ricart, Alejandro Daniel, Balakumaran, Arun and Chen, Robert W. (2016). Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Sickinger, Marie T., von Tresckow, Bastian, Kobe, Carsten, Borchmann, Peter, Engert, Andreas and Skoetz, Nicole (2016). PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis. Crit. Rev. Oncol./Hematol., 101. S. 86 - 93. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

von Tresckow, Bastian and Moskowitz, Craig H. (2016). Treatment of relapsed and refractory Hodgkin Lymphoma. Semin. Hematol., 53 (3). S. 180 - 186. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

2015

Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., Mueller, Horst, Casasnovas, Olivier, Hutchings, Martin ORCID: 0000-0003-3873-1741, von Tresckow, Bastian, Borchmann, Peter, Moskowitz, Craig and Engert, Andreas (2015). Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Goergen, Helen, Pluetschow, Annette, Behringer, Karolin, Kreissl, Stefanie, Broeckelmann, Paul, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2015). Phase II Study of Ofatumumab in Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, von Tresckow, Bastian, Boell, Boris, Behringer, Karolin, Diehl, Volker, Eich, Hans Theodor, Borchmann, Peter and Engert, Andreas (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 33 (26). S. 2857 - 2865. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas and von Tresckow, Bastian (2015). Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials. J. Clin. Oncol., 33 (22). S. 2430 - 2440. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Sickinger, Marie-Therese, von Tresckow, Bastian, Kobe, Carsten, Engert, Andreas, Borchmann, Peter and Skoetz, Nicole (2015). Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

2014

Boell, Boris, Behringer, Karolin, Goergen, Helen, Broeckelmann, Paul, von Tresckow, Bastian, Eichenauer, Dennis A., Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Behringer, Karolin, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2014). Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Thielen, Indra, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Behringer, Karolin, Halbsguth, Teresa, Klimm, Beate, Diehl, Volker, Sasse, Stephanie, Rothe, Achim, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2014). Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 123 (11). S. 1658 - 1665. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rancea, Michaela, von Tresckow, Bastian, Monsef, Ina, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis. Crit. Rev. Oncol./Hematol., 92 (1). S. 1 - 11. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

Rothe, Achim, Reiners, Katrin S., Topp, Max S., Younes, Anas, von Tresckow, Bastian, Hummel, Horst Dieter, Kessler, Joerg, Ravic, Miroslav, Marschner, Jens-Peter, von Strandmann, Elke Pogge and Engert, Andreas (2014). AFM13: an antigen specific immunotherapy for the treatment of CD30+malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL). Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., von Tresckow, Bastian, Hummel, Horst-Dieter, Ravic, Miroslav, Marschner, Jens-Peter and Engert, Andreas (2014). Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients - Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Boell, Boris, Eichenauer, Dennis, Beschorner, Denissa, Knop, Stefan, Goebeler, Maria-Elisabeth, Chemnitz, Jens Marcus, Hallek, Michael, Engert, Andreas and Huebel, Kai (2014). Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial. Leuk. Lymphoma, 55 (3). S. 695 - 698. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

von Tresckow, Bastian and Diehl, Volker (2014). An update on emerging drugs for Hodgkin lymphoma. Expert Opin Emerg. Drugs, 19 (2). S. 215 - 225. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-7623

von Tresckow, Bastian, Gundermann, Stefan, Eichenauer, Dennis A., Aulitzky, Walter Erich, Goebeler, Mariele, Sayehli, Cyrus, Bacchus, Liza, Hauns, Bernhard, Mais, Anna, Hentsch, Bernd, Kohihof, Hella, Krauss, Rolf, Krauss, Babett, Baumgartner, Roland, Vitt, Daniel and Engert, Andreas (2014). First-in-human study of 4SC-202, a novel oral HDAC inhibitor in advanced hematologic malignancies (TOPAS study). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Tresckow, Bastian, Mueller, Horst, Eichenauer, Dennis A., Glossmann, Jan P., Josting, Andreas, Boell, Boris, Klimm, Beate, Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2014). Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant. Leuk. Lymphoma, 55 (8). S. 1922 - 1925. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2013

Boell, Boris, Goergen, Helen, Arndt, Nils, Meissner, Julia, Krause, Stefan W., Schnell, Roland, von Tresckow, Bastian, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Behringer, Karalin, Klimm, Beate C., Naumann, Ralph, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 31 (35). S. 4431 - 4442. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sasse, Stephanie, Rothe, Achim, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Kreher, Stephan, Jaeger, Ulrich, Bangard, Christopher, Kuhnert, Georg, Boell, Boris, von Tresckow, Bastian and Engert, Andreas (2013). Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma. Leuk. Lymphoma, 54 (10). S. 2144 - 2149. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194

von Tresckow, Bastian and Engert, Andreas (2013). Refractory Hodgkin Lymphoma. Curr. Opin. Oncol., 25 (5). S. 463 - 470. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

2012

Klimm, Beate, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Eich, Hans Theodor, Engert, Andreas and Borchmann, Peter (2012). Discrimination of an Early Unfavorable Risk Group Has Significant Impact On Treatment Outcome in Early-Stage Hodgkin Lymphoma: An Analysis of International Staging Definitions and Risk Factors. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Rancea, Michaela, Engert, Andreas, Borchmann, Peter, von Tresckow, Bastian, Halbsguth, Teresa, Behringer, Karolin, Wongso, Diana, Boell, Boris, Klimm, Beate, Thielen, Indra, Eichenauer, Dennis A. and Skoetz, Nicole (2012). Interdisciplinary Evidence-Based Guideline for Diagnosis, Therapy and Follow-up of Adult Hodgkin Lymphoma Patients. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

von Tresckow, Bastian and Engert, Andreas (2012). The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplant. Expert Rev. Hematol., 5 (5). S. 483 - 487. LONDON: EXPERT REVIEWS. ISSN 1747-4086

2011

Boell, Boris, Bredenfeld, Henning, Goergen, Helen, Halbsguth, Teresa, Eich, Hans T., Soekler, Martin, Markova, Jana, Keller, Ulrich, Graeven, Ullrich, Kremers, Stephan, Geissler, Michael, Trenn, Guido, Fuchs, Michael, von Tresckow, Bastian, Eichenauer, Dennis A., Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood, 118 (24). S. 6292 - 6299. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2011). Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 1166 - 1168. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

von Tresckow, Bastian and Engert, Andreas (2011). The Role of Autologous Transplantation in Hodgkin Lymphoma. Curr. Hematol. Malig. Rep., 6 (3). S. 172 - 180. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X

2010

Boll, Boris, Gorgen, Helen, Fuchs, Michael, von Tresckow, Bastian, Engert, Andreas and Borchmann, Peter (2010). Feasibility and Efficacy of ABVD In Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11). Blood, 116 (21). S. 186 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

This list was generated on Fri Mar 29 01:39:32 2024 CET.